Five Developments Bringing Hope for Women, From Pay Transparency to Cancer Research

Pay transparency, access to period products and better support for people with endometriosis are among five developments offering tangible signs of progress for women. They span workplace rules, public services, personal advocacy and cancer research, with each showing how change can take shape in practical ways.

Greece puts pay rules under brighter light

New legislation in Greece, effective 1 November, requires private-sector employers to set out transparent salary structures, explain how they determine pay and address unjustified differences between men and women. Employees can request information about their own salaries and average earnings for colleagues doing equal work; employers must reply within two months. Applicants are also entitled to learn the starting salary before their first interview.

The shift matters because pay gaps can be difficult to challenge when workers lack comparable information. Clearer salary criteria and access to earnings data give employees more concrete grounds to question disparities. The change follows a recent call from the UK Equality and Human Rights Commission for workers to have a legal right to know colleagues’ salaries as a way to help prevent pay discrimination.

Free period products move closer on the Isle of Man

The Period Products (Free Provision) Act 2026 has come into force on the Isle of Man, establishing a basis for a scheme to provide free period products across the island. The scheme is still being developed, so the next detail to watch is how access will work in practice.

The legislation sets out several aims: easing period poverty, reducing stigma around menstruation and helping people manage their periods without cost becoming a barrier. Greater access could also help prevent people from missing school, work or everyday activities because they cannot afford the products they need. The law marks a step towards that goal; the planned scheme will determine how people encounter the provision day to day.

Lauren Spiezia runs New York with her scars visible

Lauren Spiezia ran the New York City Marathon topless on Sunday, displaying her mastectomy scars to raise awareness of breast cancer. Diagnosed at 31, she learned she carried the BRCA2 mutation and underwent chemotherapy, immunotherapy, a mastectomy and breast reconstruction.

“Today, I’m running the NYC Marathon with my scars uncovered, because I’m still here,” she wrote on Instagram. Spiezia said she was running for people in treatment who need a reminder of their resilience, for women who may not yet know their risk and for herself. Her message was direct: her scars, she wrote, were evidence that she had fought and lived.

Speaking to Stylist, Spiezia said she knew some people might read her choice as sexual or crude. But, she argued, the sexualising and censoring of women’s bodies contributes to breasts becoming taboo and breast health being discussed too little. She also recalled that reconstruction was the first time she had seen before-and-after photos, and said many women live with scars that remain largely unseen by society.

Her run links an intensely personal act of visibility with a wider conversation about breast health. The practical point is not that everyone should display their body; it’s that honest images and open discussion can help make experiences such as mastectomy and reconstruction less hidden.

Northern Ireland directs £1.95 million to endometriosis care

Northern Ireland is investing £1.95 million in endometriosis services, for an estimated one in 10 women in the country living with the condition and people facing long waits for diagnosis. Health minister Robbie Butler announced the funding, which is intended to improve care and support.

The two regional endometriosis centres will each receive £700,000. The remaining £1.25 million is allocated to local services and a new regional endometriosis pathway. That pathway is the part to watch: a regional approach could help organise how people move through care, while investment in local services may shape what support is available closer to home.

Butler said endometriosis can affect every part of daily life and that many women have waited for diagnosis and treatment while dealing with pain and uncertainty. The funding responds to those delays with resources for services and a new route through care. Its impact will depend on how those plans translate into timely, accessible support.

A personalised melanoma vaccine shows promise in a trial

A phase three trial has reported promising results for a personalised cancer vaccine developed by Moderna and Merck. The experimental treatment is tailored to each patient’s tumour and is designed to help the immune system recognise and attack cancer cells after surgery.

The trial involved 1,137 patients with high-risk melanoma. When the vaccine was paired with pembrolizumab, an immunotherapy drug, the risk of recurrence or death fell by 42% compared with pembrolizumab alone. The combination also reduced the risk of the cancer spreading or death by 38%.

The findings are a sign of progress in personalised cancer treatment, but the vaccine is still awaiting regulatory review and is not available as a standard treatment. For now, the results point to the approach being studied: tailoring a vaccine to an individual tumour and combining it with immunotherapy to help reduce the chance of melanoma returning.

More reads

• “My ‘baseline happiness’ is naturally low – here’s how I’m increasing it, based on advice from leading psychologists”
• Turning off emails and stretching daily: 50 tiny habits to adopt now that will instantly make you happier

Images: Getty